Norman (Ned) Sharpless, director of the National Cancer Institute, is the leading candidate to take over FDA leadership, Trump administration officials told BioCentury.
HHS Secretary Alex Azar hasn’t made a final decision, the officials said.
Brett Giroir, HHS assistant secretary for health, is also a contender.
Jim O’Neill, a libertarian opponent of requiring premarket efficacy of drugs, has expressed interest in the
